CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference

CG Oncology (NASDAQ: CGON) said its CEO Arthur Kuan and President Ambaw Bellete will present at the TD Cowen 46th Annual Health Care Conference on March 2, 2026 at 3:10 PM ET in Boston.

Rhea-AI Summary

CG Oncology (NASDAQ: CGON) said its CEO Arthur Kuan and President Ambaw Bellete will present at the TD Cowen 46th Annual Health Care Conference on March 2, 2026 at 3:10 PM ET in Boston.

Investors can listen via a live audio webcast on the company website; a replay will be archived for about 90 days after the presentation.

Argus Feb 23 session

+1.18% close to close Open Argus

Details

News Market Reaction – CGON

On Feb 23, the day this news came out, CGON closed 1.18% above the previous close.

Data tracked by StockTitan Argus for the Feb 23 session.

Market Context

This announcement highlights CG Oncology’s continued engagement with institutional investors through...

Analysis

This announcement highlights CG Oncology’s continued engagement with institutional investors through a TD Cowen conference presentation on March 2, 2026 at 3:10 pm ET, with a webcast archived for about 90 days. It follows prior investor events and major clinical updates, including accelerated PIVOT‑006 Phase 3 timing and strong NMIBC data. Investors may watch for any incremental clinical, regulatory, or commercialization commentary introduced during the presentation relative to recent filings and prior disclosures.

Key Figures

Conference date: March 2, 2026 Presentation time: 3:10 pm ET Webcast archive length: approximately 90 days

Conference date

March 2, 2026

TD Cowen 46th Annual Health Care Conference presentation

Presentation time

3:10 pm ET

Scheduled start time for TD Cowen presentation

Webcast archive length

approximately 90 days

Duration replay will be available on Investor Relations website

Historical Context

5 past events · Latest: Jan 09

5 events

1. Jan 09

   Clinical timing update

   24h Move

   +29.3%

   Moved PIVOT-006 Phase 3 topline data up to 1H 2026.

2. Jan 06

   Investor conference

   24h Move

   +0.8%

   Announced presentation at 44th J.P. Morgan Healthcare Conference.

3. Dec 18

   Research fellowship

   24h Move

   +1.7%

   Launched second NMIBC research fellowship with two $50,000 grants.

4. Dec 05

   Clinical data update

   24h Move

   -3.7%

   Reported promising BOND-003 and CORE-008 NMIBC efficacy and safety data.

5. Nov 26

   Board change

   24h Move

   -1.5%

   Added new director and noted BLA initiation for cretostimogene.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

IRVINE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman & Chief Executive Officer, and Ambaw Bellete, President & Chief Operating Officer, will present at the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026, at 3:10 pm ET. The conference is taking place at the Boston Marriott Copley Place in Boston, MA.

Interested parties may access the live audio webcast for this conference from the Investor Relations section of the company's website at www.cgoncology.com. The webcast replay will be available shortly after the conclusion of the live presentation and archived for approximately 90 days.

About CG Oncology
CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology sees a world where urologic cancer patients may benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. To learn more, please visit: www.cgoncology.com. 

Contacts
Media
Sarah Connors
Vice President, Communications and Patient Advocacy, CG Oncology
sarah.connors@cgoncology.com 

Investor Relations
Megan Knight
Vice President, Investor Relations, CG Oncology
megan.knight@cgoncology.com 

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will CG Oncology (CGON) present at the TD Cowen Health Care Conference?

CG Oncology will present on March 2, 2026 at 3:10 PM ET. According to the company, Arthur Kuan and Ambaw Bellete will deliver the presentation at the Boston Marriott Copley Place as scheduled.

Who from CG Oncology (CGON) will speak at the March 2, 2026 presentation?

The presenters are Arthur Kuan, CEO, and Ambaw Bellete, President & COO. According to the company, both executives will appear together at the TD Cowen conference session.

How can investors access the CG Oncology (CGON) webcast for the March 2 presentation?

Investors can access a live audio webcast via the company website Investor Relations section. According to the company, the webcast will stream live and a replay will be posted afterward.

Will the CG Oncology (CGON) presentation replay be available after March 2, 2026?

Yes, a replay will be available and archived for approximately 90 days. According to the company, the audio replay will appear shortly after the live presentation and remain accessible for about three months.

Where is the TD Cowen 46th Annual Health Care Conference taking place for CG Oncology's presentation?

The conference is at the Boston Marriott Copley Place in Boston, MA. According to the company, the CG Oncology presentation is scheduled during the conference program on March 2, 2026.